Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 grants and nearly $20 million awarded to California institutions for the development of tools and technologies to overcome barriers in stem cell research. Three companies who weren't awarded money filed petitions last week as the working group was finalizing its granting decisions, complaining that the grant allocations were biased toward academic institutions. CIRM President Alan Trounson, however, said he could not find "compelling evidence" to change the score of any of the applications, or the decision of the...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!